Sangamo Therapeutics
SGMO
#9855
Rank
A$81.38 M
Marketcap
A$0.20
Share price
-6.11%
Change (1 day)
-74.75%
Change (1 year)

Earnings for Sangamo Therapeutics (SGMO)

Earnings in 2025 (TTM): -A$0.18 Billion

According to Sangamo Therapeutics 's latest financial reports the company's current earnings are A$32.87 Million. In 2024 the company made an earning of -A$0.14 Billion, an increase over its 2023 earnings that were of -A$0.17 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sangamo Therapeutics from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$0.18 Billion23.1%
2024 -A$0.14 Billion-17.27%
2023 -A$0.17 Billion-40.88%
2022 -A$0.29 Billion9.79%
2021 -A$0.26 Billion41.52%
2020 -A$0.19 Billion23.17%
2019 -A$0.15 Billion36.33%
2018 -A$0.11 Billion36.89%
2017 -A$79.15 Million-22.32%
2016 -A$0.11 Billion54.86%
2015 -A$65.8 Million75.62%
2014 -A$37.47 Million0.13%
2013 -A$37.42 Million
2011 -A$50.3 Million43.66%
2010 -A$35.02 Million28.52%
2009 -A$27.25 Million-23.55%
2008 -A$35.64 Million2.45%
2007 -A$34.79 Million19.5%
2006 -A$29.11 Million50.78%
2005 -A$19.31 Million75%
2004 -A$11.04 Million-33.25%
2003 -A$16.53 Million-62.27%
2002 -A$43.81 Million102.82%
2001 -A$21.6 Million23.21%
2000 -A$17.53 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$36.47 B-23,928.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$12.75 B-8,434.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$2.27 B-1,588.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
-A$3.55 Billion 2,217.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$13.75 B-9,085.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$18.46 B-12,163.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$1.22 B-897.67%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$0.54 B-453.67%๐Ÿ‡บ๐Ÿ‡ธ USA